Additionally, we demonstrated that the expression levels of CCR7 could be of prognostic relevance and, finally, that de novo DLBCL and tFL might exhibit autocrine CCR7-CCL19 signaling. The gene discussed is CCR7; the disease is diffuse large B-cell lymphoma.